Stock Watch: Sanofi’s Vaccine Gap-Filling Aspirations
Exceeding €10bn In Vaccine Sales By 2030 Might Be A Stretch
Phase II studies of vaccines involve more variables than for drugs and these can be compounded by seasonality. This can make the time until vaccine approval longer than would be expected for drugs.
